NexgenRx Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NEGXF research report →
Price Chart
About the company
NexgenRx Inc. , established in 2003 and based in Toronto, Canada, functions as a third-party administrator for health benefit plans. The company's primary role involves efficiently managing, adjudicating, and processing payments for prescription drug, dental, and various other extended healthcare claims for individuals covered by plans offered by its clients across Canada.
- CEO
- Ronald C. Loucks
- IPO
- 2017
- Employees
- 20
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on NEGXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $30.58M
- P/E
- 18.36
- PEG
- 0.13
- P/S
- 2.29
- P/B
- 4.64
- EV/EBITDA
- 1.24
- Div Yield
- 2.54%
- Gross Margin
- 79.94%
- Op Margin
- 18.11%
- Net Margin
- 13.84%
- ROE
- 30.87%
- ROIC
- 28.63%
Latest fiscal year · YoY change
- Revenue
- $17.46M+6.0%
- Gross Profit
- $13.25M+0.9%
- Op Income
- $1.78M
- Net Income
- $1.29M+109.7%
- EPS
- $0.01+150.0%
- OCF Growth
- -87.3%
- FCF Growth
- -118.0%
- 52W High
- $0.48
- 52W Low
- $0.04
- 50D MA
- $0.37
- 200D MA
- $0.31
- Beta
- 0.46
- RSI (14)
- 54
- Avg Volume
- 688
No earnings-call transcripts are available for NEGXF yet.
- Free Float
- 63.0%
- Shares Outstanding
- 71.12M
- Float Shares
- 44.81M
Our NEGXF coverage
Recent articles, reports, and earnings notes.
No research on NEGXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NEGXF report →NexgenRx Announces Solid Q1 2026 Results with Continued Increasing Revenue, Net Income and EBITDA Growth
accessnewswire.com · May 21
NexgenRx Announces Declaration of Divdend
accessnewswire.com · Apr 17
NexgenRx Announces 2025 Year End Results with Continued Increasing Net Income, EBITDA And Revenue Growth
accessnewswire.com · Mar 31
NexgenRx Announces Declaration of Divdends
accessnewswire.com · Dec 10
NexgenRx Announces Declaration of Dividends
accessnewswire.com · Dec 10
NexgenRx Announces Significant Third Quarter Revenue and EBITDA Growth
accessnewswire.com · Nov 20
NexgenRx Announces Declaration of Dividend
accessnewswire.com · Aug 15
NexgenRx Announces Second Quarter Results with Significant Revenue Growth and Positive EBITDA
accessnewswire.com · Aug 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.